Trial · NCT02164864
Adverse events1,635
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 1,635
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Dyspnoea | Respiratory, thoracic and mediastinal disorders | Dabigatran Etexilate 110mg | 62 | 972 | |
| other | Dyspnoea | Respiratory, thoracic and mediastinal disorders | Dabigatran Etexilate 150mg | 60 | 758 | |
| other | Dyspnoea | Respiratory, thoracic and mediastinal disorders | Warfarin | 61 | 948 | |
| other | Epistaxis | Respiratory, thoracic and mediastinal disorders | Dabigatran Etexilate 110mg | 52 | 972 | |
| other | Epistaxis | Respiratory, thoracic and mediastinal disorders | Dabigatran Etexilate 150mg | 59 | 758 | |
| other | Epistaxis | Respiratory, thoracic and mediastinal disorders | Warfarin | 146 | 948 | |
| other | Haematoma | Vascular disorders | Dabigatran Etexilate 110mg | 27 | 972 | |
| other | Haematoma | Vascular disorders | Dabigatran Etexilate 150mg | 24 | 758 | |
| other | Haematoma | Vascular disorders | Warfarin | 60 | 948 | |
| serious | Anaemia | Blood and lymphatic system disorders | Dabigatran Etexilate 110mg | 6 | 972 | |
| serious | Anaemia | Blood and lymphatic system disorders | Dabigatran Etexilate 150mg | 7 | 758 | |
| serious | Anaemia | Blood and lymphatic system disorders | Warfarin | 7 | 948 | |
| serious | Anaemia macrocytic | Blood and lymphatic system disorders | Dabigatran Etexilate 110mg | 0 | 972 | |
| serious | Anaemia macrocytic | Blood and lymphatic system disorders | Dabigatran Etexilate 150mg | 1 | 758 | |
| serious | Anaemia macrocytic | Blood and lymphatic system disorders | Warfarin | 0 | 948 | |
| serious | Haemorrhagic anaemia | Blood and lymphatic system disorders | Dabigatran Etexilate 110mg | 0 | 972 | |
| serious | Haemorrhagic anaemia | Blood and lymphatic system disorders | Dabigatran Etexilate 150mg | 0 | 758 | |
| serious | Haemorrhagic anaemia | Blood and lymphatic system disorders | Warfarin | 1 | 948 | |
| serious | Iron deficiency anaemia | Blood and lymphatic system disorders | Dabigatran Etexilate 110mg | 0 | 972 | |
| serious | Iron deficiency anaemia | Blood and lymphatic system disorders | Dabigatran Etexilate 150mg | 0 | 758 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02164864/events